Evidence map›Paper›PMID 38869158›Full record

ArticleAnalytical chemistry2024

MS-PyCloud: A Cloud Computing-Based Pipeline for Proteomic and Glycoproteomic Data Analyses.

Yingwei Hu, Michael Schnaubelt, Li Chen, Bai Zhang, Trung Hoang, T Mamie Lih, Zhen Zhang, Hui Zhang

Abstract read
In one paragraph

Article in Analytical chemistry, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Yingwei HuDepartment of Pathology, School of Medicine, Johns Hopkins University, Baltimore, Maryland 21231, United States.ORCID 0000-0002-4629-0985
Michael SchnaubeltDepartment of Pathology, School of Medicine, Johns Hopkins University, Baltimore, Maryland 21231, United States.
Li ChenDepartment of Pathology, School of Medicine, Johns Hopkins University, Baltimore, Maryland 21231, United States.
Bai ZhangDepartment of Pathology, School of Medicine, Johns Hopkins University, Baltimore, Maryland 21231, United States.
Trung HoangDepartment of Pathology, School of Medicine, Johns Hopkins University, Baltimore, Maryland 21231, United States.
T Mamie LihDepartment of Pathology, School of Medicine, Johns Hopkins University, Baltimore, Maryland 21231, United States.
Zhen ZhangDepartment of Pathology, School of Medicine, Johns Hopkins University, Baltimore, Maryland 21231, United States.
Hui ZhangDepartment of Pathology, School of Medicine, Johns Hopkins University, Baltimore, Maryland 21231, United States.ORCID 0000-0001-8726-7098

Funding

Proteogenomic Characterization of Tumor Tissues and Preclinical Models with High PrecisionU24CA271079 · NCI · JOHNS HOPKINS UNIVERSITY · PI DANIEL Wanyui CHAN, Hui Zhang · 2022 to 2026
$6.6M
Glycoprotein biomarkers for the early detection of aggressive prostate cancerU01CA152813 · NCI · JOHNS HOPKINS UNIVERSITY · PI ZHANG, HUI · 2010 to 2021
$6.2M
The Comprehensive Proteome Characterization Center at Johns Hopkins: High Precision Discovery and Confirmation of Genoproteomic TargetsU24CA210985 · NCI · JOHNS HOPKINS UNIVERSITY · PI CHAN, DANIEL WANYUI, ZHANG, HUI · 2016 to 2020
$5.3M
Biomarker Reference LaboratoryU2CCA271895 · NCI · JOHNS HOPKINS UNIVERSITY · PI DANIEL Wanyui CHAN, Hui Zhang · 2023 to 2026
$4.6M
Biomarker Reference LaboratoryU2CCA271891 · NCI · JOHNS HOPKINS UNIVERSITY · PI ZHEN ZHANG · 2022 to 2026
$4.0M
Development of a panel of multiplex biomarkers for the early detection of pancreatic ductal adenocarcinoma and high-risk lesionsU01CA274514 · NCI · JOHNS HOPKINS UNIVERSITY · PI Randall Brand, DANIEL Wanyui CHAN · 2023 to 2026
$3.2M
NCI NIH HHS U01 CA152813NCI NIH HHS U01 CA274514NCI NIH HHS U24 CA210985NCI NIH HHS U24 CA271079NCI NIH HHS U2C CA271891NCI NIH HHS U2C CA271895
6 · The paper itself

Abstract

Rapid development and wide adoption of mass spectrometry-based glycoproteomic technologies have empowered scientists to study proteins and protein glycosylation in complex samples on a large scale. This progress has also created unprecedented challenges for individual laboratories to store, manage, and analyze proteomic and glycoproteomic data, both in the cost for proprietary software and high-performance computing and in the long processing time that discourages on-the-fly changes of data processing settings required in explorative and discovery analysis. We developed an open-source, cloud computing-based pipeline, MS-PyCloud, with graphical user interface (GUI), for proteomic and glycoproteomic data analysis. The major components of this pipeline include data file integrity validation, MS/MS database search for spectral assignments to peptide sequences, false discovery rate estimation, protein inference, quantitation of global protein levels, and specific glycan-modified glycopeptides as well as other modification-specific peptides such as phosphorylation, acetylation, and ubiquitination. To ensure the transparency and reproducibility of data analysis, MS-PyCloud includes open-source software tools with comprehensive testing and versioning for spectrum assignments. Leveraging public cloud computing infrastructure via Amazon Web Services (AWS), MS-PyCloud scales seamlessly based on analysis demand to achieve fast and efficient performance. Application of the pipeline to the analysis of large-scale LC-MS/MS data sets demonstrated the effectiveness and high performance of MS-PyCloud. The software can be downloaded at https://github.com/huizhanglab-jhu/ms-pycloud.

Indexed as

ProteomicsCloud ComputingGlycoproteinsHumansSoftwareTandem Mass SpectrometryGlycoproteins

Identifiers

PMID38869158
PMCPMC12038899

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.